Domov › Nemalicelični pljučni rak › Alabama › Mobile
Klinične študije za Nemalicelični pljučni rak v Mobile, AL
13 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Mobile in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Vključevanje udeležencevFaza 2/3
- Southern Cancer Center, P.C., Daphne · 10 mi stran
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Vključevanje udeležencevFaza 3
- Southern Cancer Center Pc, Daphne · 10 mi stran
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Vključevanje udeležencevFaza 3
- Southern Cancer Center Pc, Daphne · 10 mi stran
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- Southern Cancer Center, Daphne · 10 mi stran
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- Southern Cancer Center, PC, Daphne · 10 mi stran
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Infirmary Cancer Care, Mobile
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Vključevanje udeležencevFaza 3
- Local Institution - 0487, Mobile
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi stran
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi stran
- in še 1
MYLUNG Consortium Part 3: Observational Study
Vključevanje udeležencevOpazovalna študija
- Southern Cancer Center, PC, Daphne · 10 mi stran
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi stran
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi stran
- in še 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi stran
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi stran
- in še 1
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Vključevanje udeležencev
- University of South Alabama, Mobile
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Mobile
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v Mobile
- Srčno popuščanje13 študij
- Debelost7 študij
- Rak pljuč7 študij
- Rak dojke7 študij
- Rak jajčnikov7 študij
- Melanom6 študij
- Rak (vse vrste)6 študij
- Mikrocitni rak pljuč6 študij
- Srčno-žilne bolezni6 študij
- Crohnova bolezen5 študij
- Prekomerna telesna teža5 študij
- Sladkorna bolezen tipa 25 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.